J&J-Sponsored Antibiotic Trial Cited In Second Warning Letter
This article was originally published in The Pink Sheet Daily
Executive Summary
Another potential obstacle arises to the approval of Johnson & Johnson and Basilea’s investigational antibiotic ceftobiprole, as the contract research organization that conducted a clinical trial of the drug receives a warning letter.